BAVIS_1170x120_1-20

Virginia Valentine

AstraZeneca releases Bydureon BCise to U.S. pharmacies

AstraZeneca releases Bydureon BCise to U.S. pharmacies

WILMINGTON, Del. — AstraZeneca announced that Bydureon BCise (exenatide extended-release injectable suspension 2 mg) is now available in pharmacies across the United States. Bydureon BCise was recently approved by the U.S. Food and Drug Administration for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral antidiabetic medicines in addition to